Empiric Treatment of Multidrug-ResistantBurkholderia cepaciaLung Exacerbation in a Patient with Cystic Fibrosis: Application of Pharmacodynamic Concepts to Meropenem Therapy-Reference-Cited by-同舟云学术

Empiric Treatment of Multidrug-ResistantBurkholderia cepaciaLung Exacerbation in a Patient with Cystic Fibrosis: Application of Pharmacodynamic Concepts to Meropenem Therapy

Published:2004-11 Issue:11 Volume:24 Page:1641-1645
ISSN:0277-0008
Container-title:Pharmacotherapy
language:en
Short-container-title:Pharmacotherapy

Author:

Kuti Joseph L.,Moss Kerry M.,Nicolau David P.,Knauft R. Frederic

Publisher

Wiley

Subject

Pharmacology (medical)

Reference25 articles.

1. Infection Control in Cystic Fibrosis

2. Pseudomonas cepacia infection in cystic fibrosis: An emerging problem

3. Colonization of the Respiratory Tract with Pseudomonas cepacia in Cystic Fibrosis

4. Lung transplantation and the Burkholderia cepacia complex

5. Infection withBurkholderia cepaciaComplex Genomovars in Patients with Cystic Fibrosis: Virulent Transmissible Strains of Genomovar III Can ReplaceBurkholderia multivorans

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A guide to therapeutic drug monitoring of β‐lactam antibiotics;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2021-02

2. In vitro activity of meropenem/piperacillin/tazobactam triple combination therapy against clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus pseudintermedius and vancomycin-resistant Enterococcus spp;International Journal of Antimicrobial Agents;2020-02

3. Ceftolozane/tazobactam for pulmonary exacerbation in a 63-year-old cystic fibrosis patient with renal insufficiency and an elevated MIC to Pseudomonas aeruginosa;IDCases;2020

4. The effects of pharmaceutical and personal care products on the behavior of Burkholderia cepacia isolated from drinking water;International Biodeterioration & Biodegradation;2019-07

5. Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria;Journal of Antimicrobial Chemotherapy;2017-01-31